Justin Bowers
Stock Analyst at Deutsche Bank
(0.88)
# 3,590
Out of 4,829 analysts
49
Total ratings
20%
Success rate
-6.18%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $366.67 | -11.36% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $156.13 | +69.73% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $5.19 | +343.16% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.67 | +33.83% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $95.42 | +5.85% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $313.74 | +7.10% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $9.49 | +163.44% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $133.72 | +15.91% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $432.59 | +41.01% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $53.90 | +52.13% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $13.00 | +92.31% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.12 | +701.89% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $140.22 | +113.95% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $200.83 | +36.93% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $219.46 | +13.92% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $143.08 | +102.68% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $15.24 | +201.84% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $366.67
Upside: -11.36%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $156.13
Upside: +69.73%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $5.19
Upside: +343.16%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.67
Upside: +33.83%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $95.42
Upside: +5.85%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $313.74
Upside: +7.10%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $9.49
Upside: +163.44%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $133.72
Upside: +15.91%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $432.59
Upside: +41.01%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $53.90
Upside: +52.13%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $13.00
Upside: +92.31%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.12
Upside: +701.89%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $140.22
Upside: +113.95%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $200.83
Upside: +36.93%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $219.46
Upside: +13.92%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $143.08
Upside: +102.68%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $15.24
Upside: +201.84%